Objectives: Many survivors of acute respiratory distress syndrome have poor long-term outcomes possibly due to supportive care practices during "invasive" mechanical ventilation. Helmet noninvasive ventilation in acute respiratory distress syndrome may reduce intubation rates; however, it is unknown if avoiding intubation with helmet noninvasive ventilation alters the consequences of surviving acute respiratory distress syndrome. Design: Long-term follow-up data from a previously published randomized controlled trial. Patients: Adults patients with acute respiratory distress syndrome enrolled in a previously published clinical trial. Setting: Adult ICU. Intervention: None. Measurements and Main Results: The primary outcome was functional independence at 1 year after hospital discharge defined as independence in activities of daily living and ambulation. At 1 year, patients were surveyed to assess for functional independence, survival, and number of institution-free days, defined as days alive spent living at home. The presence of ICU-acquired weakness and functional independence was also assessed by a blinded therapist on hospital discharge. On hospital discharge, there was a greater prevalence of ICU-acquired weakness (79.5% vs 38.6%; p = 0.0002) and less functional independence (15.4% vs 50%; p = 0.001) in the facemask group. One-year follow-up data were collected for 81 of 83 patients (97.6%). One-year mortality was higher in the facemask group (69.2% vs 43.2%; p = 0.017). At 1 year, patients in the helmet group were more likely to be functionally independent (40.9% vs 15.4%; p = 0.015) and had more institution-free days (median, 268.5 [0-354] 
S urviving acute respiratory distress syndrome (ARDS) is only the beginning of a prolonged recovery phase marked by neuromuscular weakness, functional impairment, and increased healthcare utilization (1) . The complications that many ARDS survivors are set to inherit may be a consequence of supportive care practices that include deep sedation, neuromuscular blockade, and bed rest, which lay the foundation for persistent disability. Although some have shown that early mobilization during invasive mechanical ventilation improves functional impairment (2) , data regarding its long-term benefits are lacking (3) . Furthermore, despite its short-term benefits, implementation of early mobilization in invasively mechanically ventilated may be challenging (4, 5) given that the mere presence of an endotracheal tube is often considered a major barrier to therapy (6) . Therefore, if the cost of surviving invasive mechanical ventilation for ARDS is not readily modified by early mobilization, we wondered if successful use of noninvasive ventilation (NIV) in ARDS has the potential to alter short-and long-term outcomes. Our group has recently shown in a randomized clinical trial that NIV using a helmet interface can reduce intubation rates and improve mortality in patients with ARDS in comparison to facemask NIV (7) . However, it remains unknown if helmet NIV alters the longterm complications of surviving ARDS. The primary aim of this 1-year follow-up study is to describe and compare the functional outcomes patients of ARDS patients enrolled in a randomized clinical trial of helmet versus facemask NIV.
METHODS
The results from helmet versus facemask NIV, a single-center randomized clinical trial in patients with ARDS, have been previously reported (7) . Briefly, patients admitted to the medical ICU with ARDS requiring facemask NIV for at least 8 hours were eligible for enrollment. The institutional review board approved the study, and informed written consent was obtained from participants or their authorized surrogate decision maker. Patients were randomly assigned to continue on NIV using the facemask (n = 39) or switch to the helmet interface (n = 44). The primary endpoint was the intubation rate, which was observed to be over 40% lower in the helmet NIV group. This result and other considerations led to discontinuation of the trial, as described in the primary report (7) .
Baseline functional independence was determined by Barthel Index score greater than or equal to 70 obtained from the patient or a proxy describing patient function 2 weeks before admission (8, 9) . All enrolled patients received physical and occupational therapy during their ICU stay. The number of mobility sessions completed during the ICU stay and mobilization milestones such as completion of upper/lower extremity exercises, bed mobility, sitting on edge of bed, standing, sitting in a chair, and ambulating were also recorded for each ICU mobility session. If patients were not mobilized, the treating therapist was required to provide a reason for deferring the session (10) . Given that ICU length of stay was different between groups, the total number of ICU days patients were mobilized was divided by the total number of ICU days to calculate the proportion of ICU days that patients were mobilized in each group. Delirium was assessed after interruption of sedation (11) , using the Confusion Assessment Method ICU (CAM-ICU) (12) . Patients with contraindication to sedative interruption (i.e., neuromuscular blockade) were assessed while on sedative. The proportion of days spent in delirium, coma, or CAM-ICU normal were calculated by dividing the total number of days in each cognitive category by the total ICU or hospital days for each group.
All patients who survived to hospital discharge had a functional and strength assessment using the Medical Research Council (MRC) scale by a therapist who was blinded to study allocation (13) . A combined MRC score of less than 48 defined the presence of ICU-acquired weakness (ICU-AW) (14) . Patients who died during their hospitalization without a strength assessment were recorded as having ICU-AW. Functional independence at hospital discharge was defined as independence in all activities of daily living (ADLs) and independent ambulation as determined by a blinded therapist (2) .
At 1 year after hospital discharge, patients were interviewed by phone to assess survival and functional independence. Functional independence at 1 year was defined as independence in all ADLs and independent ambulation as reported by the patient. We prospectively collected data on hospital, skilled nursing, long-term acute care, and rehabilitation facility admissions using patient interview corroborated by medical records to calculate the number of healthcare institution-free days, defined as days alive spent living at home. Deaths were also assessed using the social security death index.
Statistical Analysis
All analyses were performed on the basis of an intention-totreat approach. We used the chi-square test or Fisher exact test as appropriate to compare categorical outcomes between groups. Wilcoxon Mann-Whitney U two-sample rank-sum test (for medians) or t tests (for means) were used to compare continuous outcomes. To evaluate the effect of the intervention on 1-year survival, we used the Kaplan-Meier procedure to estimate survival distributions in each group, with the effect of the intervention compared between groups using the log-rank test. Additional analyses were done with Cox regression models that adjusted for baseline factors that predict outcomes (age and Acute Physiology and Chronic Health Evaluation [APACHE] II) and the presence of the helmet intervention. Hazard ratios (HRs), together with 95% CIs, were estimated using this model. We used Stata 11.0 software (StataCorp LP, College, Station, TX).
Role of the Funding Source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
RESULTS

Baseline Characteristics
The majority of the patients who survived to hospital discharge resided at home (50/52 survivors; 96%) and were functionally independent (43/52 survivors; 87%) prior to their hospitalization ( Table 1) . There was no difference in severity of ICU illness between groups (APACHE II score 24 in the facemask group vs 25 in helmet group; p = 0.97).
Short-Term Functional and Neuromuscular Outcomes
Patients in the helmet group had a greater proportion of ICU days with early mobilization as compared to patients in the facemask group (51.6% [111/215 ICU days] vs 38.4% [110/286 ICU days]; p = 0.003). This difference in the number of mobilization sessions was primarily seen during the time patients were on NIV ( Table 2) . Patients in the helmet group participated in mobilization 63.6% of the days while on NIV as compared to 43.9% in the facemask group (p = 0.02). There was no difference in completion of upper/ lower extremity (90.9% vs 76.9%; p = 0.13) or bed mobility exercises (90.9% vs 74.4%; p = 0.08) between groups. However, more patients in the helmet group were able to sit at the edge of the bed (90.9% vs 69.2%; p = 0.02), stand (84.1% vs 56.4%; p = 0.006), transfer to a chair (77.3% vs 51.3%; p = 0.01), and walk (70.5% vs 41%; p = 0.007) as compared to the facemask group.
Upon hospital discharge, there was a significant reduction in the proportion of patients with ICU-AW in the helmet group as compared to the facemask group (38.6% vs 79.5%; p = 0.0002). In addition, more patients in the helmet group were functionally independent on hospital discharge than the facemask group (50% vs 15.4%; p = 0.001). After excluding patients who died during their hospitalization, these differences in the presence of ICU-AW (helmet 18.8% vs facemask 60%; p = 0.002) and functional independence (helmet 68.8% vs facemask 30%; p = 0.006) remained statistically significant.
Neurocognitive Outcomes
Both groups had similar sedative use ( 
One-Year Follow-Up Outcomes
Eighty-one of the 83 enrolled patients underwent 1-year follow-up (97.6%) (Supplemental Fig. 1 diagram of patient flow through 1 year after randomization.). Upon hospital discharge, 47.7% of the helmet group (Table 4) returned home in comparison with 20.5% of patients in the facemask group (p = 0.009). A greater proportion of patients in the helmet group were alive and functionally independent at 1 year than in the facemask group (40.9% vs 15.4%; p = 0.015). After excluding patients who died during their hospitalization, 30% of the patients in the facemask were functionally independent at 1 year as compared to 56.3% in the helmet group (p = 0.06). In addition, patients in the helmet group had significantly more healthcare institution-free days than patients in the facemask group (268.5 vs 0 d; p = 0.017). Finally, the helmet group had lower 1-year mortality than the facemask group (43.2% vs 69.2%; log-rank test for difference in survival distributions; p = 0.007) (Fig. 1) 
DISCUSSION
In a long-term follow-up study of our trial of helmet NIV (7), we found that patients in the helmet group were more likely to be discharged home, functionally independent and remain independent at 1 year after ICU admission in comparison with facemask NIV. The helmet group also had improved 1 year survival and less healthcare utilization. These findings are in stark contrast to prior work demonstrating persistent functional limitations, poor quality of life, and increased healthcare utilization in invasively mechanically ventilated ARDS survivors after critical illness (1). The complications described by Herridge et al (1, 15) may be a direct result of supportive care practices in the management of ARDS which include bed rest, neuromuscular blockade, and deep sedation during invasive mechanical ventilation. One should be cautious directly comparing our work with the cohort by Herridge et al (1, 15) , since all of those patients were intubated, whereas many in our cohort did not require endotracheal intubation. However, interventions aimed at mitigating the complications of invasive mechanical ventilation such as mobilization, while possible in intubated patients (2) , are more challenging to implement than in nonintubated patients (6) . Although NIV has the promise to avoid the complications of "invasive" ventilation (16), many have cautioned against its use in hypoxemic respiratory failure due to high failure rates (17, 18) and concerns for excess mortality (19) possibly from delayed intubation and/or large tidal volumes (20, 21) . Our prior work suggests that mortality and endotracheal intubation rates for NIV in ARDS may be significantly improved when the interface for the delivery of NIV is a helmet (7) . Therefore, the avoidance of complications of invasive mechanical ventilation could be possible with helmet ventilation without excess risk from high failure rates and mortality. Further work is needed to draw more definitive conclusions on this issue. The prevention of functional and neuromuscular complications in the helmet group may be explained by the avoidance of immobility and deep sedation practices that may be associated with invasive mechanical ventilation. Indeed, the helmet group was mobilized more reliably in the ICU, had less delirium, and had less neuromuscular weakness on hospital discharge. The ability to effectively implement early mobilization during the NIV was key to setting a path for functional recovery after ARDS.
Our study has several limitations. First, the original trial of helmet NIV was stopped early for efficacy and safety concerns in accord with predefined criteria by our Data Safety and Monitoring Board. This may alter the magnitude of the longterm effects of this intervention. Second, functional independence at 1 year was determined by patient self-report, which can underestimate any impairment. However, there are data suggesting acceptable agreement in ADL proficiency by selfreport and direct observation (22) . Third, the study was not blinded which may introduce bias especially with the implementation of early mobilization. To investigate this possibility, therapists cited reasons for deferred mobility sessions. There was no difference in most reasons for missed mobility sessions, except for increased neuromuscular blockade on potential mobility days in the helmet group (16% vs 4%; p = 0.0002). The reasons for missed mobility sessions were not expected to be all inclusive, and thus secondary reasons omitted by the therapists for the control group may have included neuromuscular blockade. In addition, therapists cited graduation from therapy due to achievement of functional independence more commonly in the helmet group (3% vs 0%; p = 0.02) and increased patient refusal of mobilization in the facemask group (10% vs 1%; p = 0.001). The most common reason cited as to why patients refused was fatigue in the facemask group (15/18 times; 83.3%). These data support our observation of patient intolerance of the facemask which limited the implementation of early mobilization during NIV in the control group.
Recent work has cautioned against the use of NIV in the management of ARDS in deference to the primacy of instituting lung-protective strategy with invasive mechanical ventilation (21, 23) . This choice may reduce the risk of perpetuating lung injury but often necessitates deep sedation practices and bed rest which are at the cost of functional independence. Our work suggests a possible alternative approach in which helmet ventilation obviates the need for invasive mechanical ventilation and its associated detrimental supportive care practices. Patients have the opportunity to be awake and animated in spite of highly assisted spontaneous breathing during ARDS to set a foundation for functional "recovery" after ARDS. To date, there have been no interventions shown to improve longterm outcomes in ARDS survivors. Although these findings are preliminary, the potential of helmet noninvasive to alter the landscape of ARDS survivorship warrants further study. 
